Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration

Molecular Therapy

Volumn 7, Issue 3, 2003, Pages 409-418

  Ito, Isao ^a   Began, Gopalan ^a   Mohiuddin, Imran ^a   Saeki, Tomoyuki ^a   Saito, Yuji ^a   Branch, Cynthia D ^a   Vaporciyan, Ara ^a   Stephens, L Clifton ^a   Yen, Nancy ^a   Roth, Jack A ^a   Ramesh, Rajagopal ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Gene therapy; Liposome; Metastasis; Phagocytosis

Indexed keywords

FLUORESCENT DYE; LIPOSOME; LUCIFERASE; PLASMID DNA; PLASMID VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG FORMULATION; DRUG UPTAKE; EXPLANT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LUNG PARENCHYMA; LUNG RESECTION; LUNG TUMOR; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PHAGOCYTOSIS; TRANSGENE; TUMOR CELL;

ANIMALIA; MURINAE;

EID: 0037367441     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00004-2     Document Type: Article

References (48)

1. Swisher, S. G., et al. (1999). Adenoviral mediated p53 gene transfer in advanced non-small cell lung cancer. J. Natl. Cancer Inst. 91: 763-771.
2. Roth, J. A., et al. (1996). Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat. Med. 2: 985-991.
3. Clayman, G. L, et al. (1998). Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J. Clin. Oncol. 16: 2221-2232.
4. Nabel, G. J., et al. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90: 11307-11311.
5. Hung, M. C., Wang, S. C., and Hortobagyi, G. (1999). Targeted HER-2/neu-overexpressing cancer cells with transcriptional repressor genes delivered by cationic liposome). In Non Viral Vectors for Gene Therapy (L. Huang, M. C. Hung, and E. Wagner, Eds.), pp. 357-377. Academic Press, San Diego.
6. Nemunaitis, J., et al. (2000). Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J. Clin Oncol. 18: 609-622.
7. Templeton, N. S., et al. (1997). Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat. Biotechnol. 15: 647-652.
8. Kurane, S., et al. (1998). Targeted gene transfer of adenocarcinoma using a combination of tumor-specific antibody and tissue-specific promoter. Jpn. J. Cancer Res. 89: 1212-1219.
9. Kunitomi, M., et al. (2000). Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene. Jpn. J. Cancer Res. 91: 343-350.
10. Chen, J., et al. (1998). Targeted in vivo delivery of therapeutic gene into experimental squamous cell carcinomas using anti-epidermal growth factor receptor antibody: immunogene approach. Hum. Gene Ther. 9: 2673-2681.
11. Park, J. W., et al. (1995). Development of anti-p185HER2 immuno-liposomes for cancer therapy. Proc. Natl. Acad. Sci. USA 92: 1327-1331.
12. Hara, T., et al. (1995). Receptor mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposome. Gene Ther. 2: 784-788.
13. Lee, R. J., and Huang, L. (1996). Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271: 8481-8487.
14. Xu, L., Pirollo, K. F., and Chang, E. H. (1997). Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro. Hum. Gene Ther. 8: 467-475.
15. Woodle, M. C., et al. (1992). Versatility of lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim. Biophys. Acta 1105: 193-200.
16. Harrington, K. J., et al. (2001). Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin. Cancer Res. 7: 243-254.
17. Li, S., et al. (1998). Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther. 5: 930-997.
18. Li, S., et al. (1999). Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am. J. Physiol. 276: L796-L804.
19. Freimark, B. D., et al. (1998). Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid-cationic lipid complexes. J. Immunol. 160: 4580-4586.
20. Tan, Y., et al. (1999). The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector mediated transgene expression in vivo. Hum. Gene Ther. 10: 2153-2161.
21. Dow, S. W., et al. (1999). Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J. Immunol. 163: 1552-1561.
22. Qin, L., et al. (1997). Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor alpha inhibit transgene expression. Hum. Gene Ther. 8: 2019-2029.
23. Song, Y. K., et al. (1997). Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum. Gene Ther. 8: 1585-1594.
24. Ramesh, R., et al. (2001). Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. Mol. Ther. 3: 337-350, doi:10.1006/mthe.2001.0266.
25. Slocum, H. K., et al. (1981). Characterization of cells obtained by mechanical and enzymatic means from human melanoma, sarcoma and lung tumors. Cancer Res. 41: 1428-1434.
26. Gaensler, K. M. L., et al. (1999). Fetal gene transfer by transuterine injection of cationic liposome-DNA complexes. Nat. Biotechnol. 17: 1188-1192.
27. Sparrow, C. P., et al. (1999). A fluorescent cholesterol analog traces cholesterol absorption in hamsters and is essential in vivo and in vitro. J. Lipid Res. 40: 1747-1757.
28. Matsui, H., Johnson, L. G., Randell, S. H., and Boucher, R. C. (1997). Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells. J. Biol. Chem. 272: 1117-1126.
29. Moxley, M. A., Baird, T. L., and Corbett, J. A. (2000). Adoptive transfer of acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 279: 985-993.
30. Takeshita, S., et al. (1994). Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury. J. Clin. Invest. 93: 652-661.
31. Schramlova, J., et al. (1997). Electron microscopic demonstration of the interaction of liposomes and cells in vitro. Folia Biol. 43: 161-167.
32. Mallery, S. R., et al. (2000). Controlled-release of doxorubicin from poly(lactide-coglycolide) microspheres significantly enhances cytotoxicity against cultured AIDS-related Kaposi's sarcoma cells. Anticancer Res. 20: 2817-2825.
33. Friend, D. S., Papahadjopoulos, D., and Debs, R. J. (1996). Endocytosis and intracellular processing accompanying transfection mediated by cationic liposome. Biochim. Biophys. Acta 1278: 41-50.
34. Chu, Q., et al. (1999). Binding and uptake of cationic lipid: DNA complexes by polarized airway epithelial cells. Hum. Gene Ther. 10: 25-36.
35. Barry M. E., et al. (1999). Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum. Gene Ther. 10: 2461-2480.
36. Zabner, J., et al. (1995). Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270: 18997-19007.
37. King, C. A., and Preston, T. M. (1977). Fluoresceinated cationised ferritin as a membrane probe for anionic sites at the cell surface. FEBS Lett. 73: 59-63.
38. Williams, M. C. (1984). Endocytosis in alveolar type II cells: effect of charge and size of tracers. Proc. Natl. Acad. Sci. USA 81: 6054-6058.
39. Ryser, H., Caulfield, J. B., and Aub, J. C. (1962). Studies on protein uptake by isolated tumor cells. J. Cell Biol. 14: 255-268.
40. Anwer, K., et al. (2000). Cationic lipid-based delivery system for systemic cancer gene therapy. Cancer Gene Ther. 7: 1156-1164.
41. Thurston, G., et al. (1998). Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J. Clin. Invest. 101: 1401-1413.
42. Elmslie, R., Thamm, D., MacEwen, G., and Dow, S. (2001). Inhibition of tumor angiogenesis by systemic gene delivery in dogs with soft tissue sarcomas. Proc. Am. Assoc. Cancer Res. 42: 704 [Abstract].
43. Liu, Y., et al. (1999). Systemic gene delivery expands the repertoire of effective antiangiogenic agents. J. Biol. Chem. 274: 13338-13344.
44. McLean, J. W., Thurston, G., and McDonald, D. M. (1999). Sites of uptake and expression of cationic liposome/DNA complexes injected intravenously). In Non Viral Vectors for Gene Therapy (L. Huang, M. C. Hung, and E. Wagner, Eds.), pp. 119-135. Academic Press, San Diego.
45. Liu, Y., et al. (1997). Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat. Biotechnol. 15: 167-173.
46. Sotomayor, E. M., et al. (1991). Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. J. Immunol. 147: 2816-2823.
47. Lopez, D. M., et al. (1996). Cytokine production by lymphoreticular cells from mammary tumor bearing mice: the role of tumor derived factors. Anticancer Res. 16: 3923-3930.
48. Sotomayor, E. M., et al. (1993). Impaired activation of tumoricidal function in macrophages from mammary tumor bearers: the role of IFN-γ. Int. J. Oncol. 3: 719-727.